United States (US) Oncology Based Molecular Diagnostics Market (2025-2031) | Value, Segmentation, Competitive Landscape, Forecast, Trends, Outlook, Industry, Size & Revenue, Analysis, Share, Growth, Companies

Name: United States (US) Oncology Based Molecular Diagnostics Market (2025-2031) | Value & Segmentation
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Others), By Technology (PCR, In situ hybridization, INAAT, Chips and microarrays, Mass spectrometry, Sequencing, TMA, Others), By Product (Instruments, Reagents, Others) And Competitive Landscape

Product Code: ETC9972028	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Oncology Based Molecular Diagnostics Market Outlook
Market Size of United States (US) Oncology Based Molecular Diagnostics Market, 2024
Forecast of United States (US) Oncology Based Molecular Diagnostics Market, 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Revenues & Volume for the Period 2021- 2031
United States (US) Oncology Based Molecular Diagnostics Market Trend Evolution
United States (US) Oncology Based Molecular Diagnostics Market Drivers and Challenges
United States (US) Oncology Based Molecular Diagnostics Price Trends
United States (US) Oncology Based Molecular Diagnostics Porter's Five Forces
United States (US) Oncology Based Molecular Diagnostics Industry Life Cycle
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Cervical Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Blood Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Breast Cancer Oncology Based Molecular Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Technology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By PCR for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By In situ hybridization for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By INAAT for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Chips and microarrays for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Mass spectrometry for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Sequencing for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By TMA for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Product for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Instruments for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Reagents for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Oncology Based Molecular Diagnostics Import Export Trade Statistics
Market Opportunity Assessment By Type
Market Opportunity Assessment By Technology
Market Opportunity Assessment By Product
United States (US) Oncology Based Molecular Diagnostics Top Companies Market Share
United States (US) Oncology Based Molecular Diagnostics Competitive Benchmarking By Technical and Operational Parameters
United States (US) Oncology Based Molecular Diagnostics Company Profiles
United States (US) Oncology Based Molecular Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Oncology Based Molecular Diagnostics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oncology Based Molecular Diagnostics Market - Industry Life Cycle

3.4 United States (US) Oncology Based Molecular Diagnostics Market - Porter's Five Forces

3.5 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

4 United States (US) Oncology Based Molecular Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer cases in the United States

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Technological advancements in molecular diagnostics for oncology

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of molecular diagnostic tests

4.3.2 High costs associated with molecular diagnostics testing

4.3.3 Limited accessibility to molecular diagnostics services in certain regions

5 United States (US) Oncology Based Molecular Diagnostics Market Trends

6 United States (US) Oncology Based Molecular Diagnostics Market, By Types

6.1 United States (US) Oncology Based Molecular Diagnostics Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.4 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.5 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.1.6 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F

6.1.7 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.1.8 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.9 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.1.10 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Oncology Based Molecular Diagnostics Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F

6.2.3 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By In situ hybridization, 2021- 2031F

6.2.4 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By INAAT, 2021- 2031F

6.2.5 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Chips and microarrays, 2021- 2031F

6.2.6 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Mass spectrometry, 2021- 2031F

6.2.7 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.8 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2.9 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Oncology Based Molecular Diagnostics Market, By Product

6.3.1 Overview and Analysis

6.3.2 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F

6.3.3 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Reagents, 2021- 2031F

6.3.4 United States (US) Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Oncology Based Molecular Diagnostics Market Import-Export Trade Statistics

7.1 United States (US) Oncology Based Molecular Diagnostics Market Export to Major Countries

7.2 United States (US) Oncology Based Molecular Diagnostics Market Imports from Major Countries

8 United States (US) Oncology Based Molecular Diagnostics Market Key Performance Indicators

8.1 Adoption rate of molecular diagnostic tests in oncology clinics/hospitals

8.2 Number of partnerships and collaborations in the oncology molecular diagnostics sector

8.3 Research and development investments in innovative molecular diagnostics technologies for oncology

9 United States (US) Oncology Based Molecular Diagnostics Market - Opportunity Assessment

9.1 United States (US) Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

10 United States (US) Oncology Based Molecular Diagnostics Market - Competitive Landscape

10.1 United States (US) Oncology Based Molecular Diagnostics Market Revenue Share, By Companies, 2024

10.2 United States (US) Oncology Based Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Oncology Based Molecular Diagnostics Market

Estonia Oncology Based Molecular Diagnostics Market

Ethiopia Oncology Based Molecular Diagnostics Market

Fiji Oncology Based Molecular Diagnostics Market

Finland Oncology Based Molecular Diagnostics Market

Gabon Oncology Based Molecular Diagnostics Market

Global Oncology Based Molecular Diagnostics Market

Middle East Oncology Based Molecular Diagnostics Market

North America Oncology Based Molecular Diagnostics Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here